We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.22B
AUM Growth
+$476M
Cap. Flow
+$875M
Cap. Flow %
16.78%
Top 10 Hldgs %
15.66%
Holding
2,088
New
521
Increased
591
Reduced
504
Closed
422

Sector Composition

Rank Sector Weight
1 Technology 18.15%
2 Consumer Discretionary 13.85%
3 Healthcare 12.47%
4 Industrials 10.55%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
501
Everpure Inc
P
$29.9B
$2.6M 0.05%
108,587
-39,445
-27% -$867K
QNST icon
502
QuinStreet
QNST
$1.21B
$2.6M 0.05%
202,861
-6,381
-3% -$80.4K
HLNE icon
503
Hamilton Lane
HLNE
$5.57B
$2.6M 0.05%
53,892
-13,970
-21% -$614K
CRZO
504
DELISTED
Carrizo Oil & Gas Inc
CRZO
$2.6M 0.05%
93,052
+65,661
+240% +$1.51M
CRC
505
DELISTED
California Resources Corporation
CRC
$2.59M 0.05%
+57,769
New +$1.83M
HZNP
506
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.58M 0.05%
156,355
+11,494
+8% +$175K
HII icon
507
Huntington Ingalls Industries
HII
$12.8B
$2.58M 0.05%
+11,896
New +$2.76M
FFIV icon
508
F5
FFIV
$22.7B
$2.58M 0.05%
14,799
-18,760
-56% -$3.13M
MGLN
509
DELISTED
Magellan Health Services, Inc.
MGLN
$2.58M 0.05%
26,835
-5,675
-17% -$544K
VSTO
510
DELISTED
Vista Outdoor Inc.
VSTO
$2.57M 0.05%
163,071
-179,158
-52% -$2.87M
ANIP icon
511
ANI Pharmaceuticals
ANIP
$1.78B
$2.57M 0.05%
38,233
-13,803
-27% -$862K
INGR icon
512
Ingredion
INGR
$6.58B
$2.57M 0.05%
23,166
+13,697
+145% +$1.61M
PTCT icon
513
PTC Therapeutics
PTCT
$6.12B
$2.57M 0.05%
77,631
+65,466
+538% +$2.04M
CMA
514
DELISTED
Comerica
CMA
$2.56M 0.05%
27,920
-13,131
-32% -$1.26M
OMF icon
515
OneMain Financial
OMF
$7.47B
$2.55M 0.05%
75,842
+52,244
+221% +$1.69M
CPA icon
516
Copa Holdings
CPA
$5.8B
$2.55M 0.05%
27,059
+20,806
+333% +$2.33M
EEX
517
DELISTED
Emerald Holding
EEX
$2.54M 0.05%
124,387
+70,461
+131% +$1.42M
GEF icon
518
Greif
GEF
$5.04B
$2.54M 0.05%
47,407
+31,879
+205% +$1.83M
PARA
519
DELISTED
Paramount Global Class B
PARA
$2.54M 0.05%
+45,318
New +$2.37M
WLY icon
520
John Wiley & Sons Class A
WLY
$2.66B
$2.54M 0.05%
40,404
+1,194
+3% +$79.3K
MRT
521
DELISTED
MedEquities Realty Trust, Inc.
MRT
$2.53M 0.05%
228,976
+6,434
+3% +$66.4K
ADNT icon
522
Adient
ADNT
$1.5B
$2.53M 0.05%
51,357
+22,044
+75% +$1.25M
PLUS icon
523
ePlus
PLUS
$2.34B
$2.52M 0.05%
53,468
+540
+1% +$23.6K
SWKS icon
524
Skyworks Solutions
SWKS
$10.6B
$2.52M 0.05%
26,021
+4,830
+23% +$469K
CNMD icon
525
CONMED
CNMD
$1.47B
$2.52M 0.05%
34,467
-6,730
-16% -$458K

Similar funds

Oxford Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Oxford Asset Management held 2,088 positions worth $5.22B, up 10% from $4.74B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oxford Asset Management deployed $875M of net new capital in Q2 2018, opening 521 new positions and adding to 591 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 735,572 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $59.4M trimmed.

  • Oxford Asset Management's largest Q2 2018 buy was Twenty-First Century Fox, Inc. Class B: 735,572 shares worth $36.3M.
  • Oxford Asset Management added most to Envision Healthcare Holdings Inc in Q2 2018, an estimated $86.9M increase.
  • Oxford Asset Management's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $59.4M.
  • Oxford Asset Management fully exited Time Warner Inc in Q2 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 16% of its $5.22B portfolio in Q2 2018.
  • Oxford Asset Management opened 521 new positions and closed 422 in Q2 2018.
  • Oxford Asset Management's portfolio value rose 10% quarter-over-quarter to $5.22B.

Based on Oxford Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.